Glucagon/PP-related
peptides were detected immunohistochemically in 18 out of 22 cases of
rectal tumors investigated. The reactive
tumors showed prevalence of trabecular or mixed trabecular-acinar structure and moderate staining with Grimelius'
silver and lead-
hematoxylin. Three of the remaining 4 cases were characterized by reactivity for
5-hydroxytryptamine only, prevalence of a solid nest structural component and intense staining with Grimelius'
silver technique and lead-
hematoxylin. Fifteen of the 18
glucagon/PP-reactive cases were investigated immunohistochemically with a series of 6 sera directed against different sequences of
glucagon,
glicentin and
proglucagon, and of 7 sera directed against PP, PYY and proPP-icosapeptide. A large spectrum of
glucagon-related immunoreactivities, including C-terminus and mid-portion
glucagon-immunoreactivity, N- and C-terminus
glicentin-immunoreactivity, GLP1- and GLP2-immunoreactivity, were detected in human rectal L cells and most rectal
carcinoids. With the exception of a few scattered cells in the rectal mucosa and in 3
tumors, C-terminus
glucagon-immunoreactivity was obtained only after
trypsin or
subtilisin treatment of tissue sections. Both PYY and PP/proPP-like
peptide(s) were detected in rectal L cells and
carcinoids, with prevalence of PYY in normal cells and PP/proPP-like
peptides in
tumor cells. It is concluded that the same or closely related
hormone/prohormone sequences are synthesized and stored in rectal endocrine cells and
carcinoid tumors although differences of quantitative expression, post-translational cleavage or reactivity to
antibodies may occur. The usefulness of
protease treatments of tissue sections to unmask immunoreactivities of uncleaved propeptides or
fixative-denatured
peptides is outlined.